Technology tamfitronics
- News in Brief
- Published:
Nature Biotechnology volume42,page 1001 (2024)Cite this article
AstraZeneca and Pfizer will invest almost $1 billion in manufacturing in France. Pfizer will invest $539 million to build R&D capabilities, and AstraZeneca will spend $388 million to upgrade its Dunkirk site.
The Coalition for Epidemic Preparedness Innovations awards BioNTech $145 million to build a network in Africa for producing mRNA-based vaccines for malaria, mpox, tuberculosis and other diseases. The funding expands on the German biotechs agreement to build an mRNA vaccine manufacturing site in Kigali, Rwandas capital.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
24,99 /30days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
214,86 per year
only 17,91 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Biotech news from around the world. Nat Biotechnol 421001 (2024). https://doi.org/10.1038/s41587-024-02328-7
-
Published:
-
Issue Date:
-
DOI: https://doi.org/10.1038/s41587-024-02328-7
